1.
Diabetes Care
; 43(11): e170-e171, 2020 11.
Article
in English
| MEDLINE
| ID: mdl-32816997
2.
Arch Dis Child Educ Pract Ed
; 105(4): 222-224, 2020 08.
Article
in English
| MEDLINE
| ID: mdl-30661016
Subject(s)
Abnormalities, Multiple/diagnosis , Bone Diseases, Developmental/diagnosis , Cafe-au-Lait Spots/diagnosis , Diagnostic Techniques and Procedures/standards , Neurofibromatosis 1/diagnosis , Practice Guidelines as Topic , Symptom Assessment/standards , Asian People , Female , Humans , Infant , Leg/diagnostic imaging , United Kingdom
3.
BMJ Case Rep
; 20132013 Jan 29.
Article
in English
| MEDLINE
| ID: mdl-23365164
ABSTRACT
A 5-year-old boy presented with neutropenia 9 weeks following the administration of rituximab for management of his steroid-dependent nephrotic syndrome. Extensive investigations failed to identify any underlying cause. In keeping with adult reports, rituximab was thought to be the likely cause for this 'late-onset' neutropenia (LOP). He was treated successfully with granulocyte-colony-stimulating factor. Patients treated with rituximab need to be carefully monitored for LOP.
